
    
      A Phase III, Multicentre, Randomised, Double-Blind Comparative Study to Evaluate the Efficacy
      and Safety of Ceftaroline Fosamil (600 mg every 8 hours) Versus Vancomycin Plus Aztreonam in
      the Treatment of Patients with Complicated Bacterial Skin and Soft Tissue Infections With
      Evidence of Systemic Inflammatory Response or Underlying Comorbidities
    
  